Global Spinal Muscular Atrophy (SMA) Therapeutic Market Research Report 2024(Status and Outlook)
Report Overview
Spinal muscular atrophy treatment market growth is driven by a significant increase in the number of product launches despite the relative rarity of the disorder and high costs associated with the approved drugs. The treatment of spinal muscular atrophy through the gene therapy drug called Zolgensma
This report provides a deep insight into the global Spinal Muscular Atrophy (SMA) Therapeutic market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Spinal Muscular Atrophy (SMA) Therapeutic Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Spinal Muscular Atrophy (SMA) Therapeutic market in any manner.
Global Spinal Muscular Atrophy (SMA) Therapeutic Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Biogen
Novartis
Roche
Astellas Pharma
Genzyme Corporation
Market Segmentation (by Type)
Nusinersen
Onasemnogen Abeparvovec
Market Segmentation (by Application)
Type 1 SMA
Type 2 SMA
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Spinal Muscular Atrophy (SMA) Therapeutic Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Spinal muscular atrophy treatment market growth is driven by a significant increase in the number of product launches despite the relative rarity of the disorder and high costs associated with the approved drugs. The treatment of spinal muscular atrophy through the gene therapy drug called Zolgensma
This report provides a deep insight into the global Spinal Muscular Atrophy (SMA) Therapeutic market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Spinal Muscular Atrophy (SMA) Therapeutic Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Spinal Muscular Atrophy (SMA) Therapeutic market in any manner.
Global Spinal Muscular Atrophy (SMA) Therapeutic Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Biogen
Novartis
Roche
Astellas Pharma
Genzyme Corporation
Market Segmentation (by Type)
Nusinersen
Onasemnogen Abeparvovec
Market Segmentation (by Application)
Type 1 SMA
Type 2 SMA
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Spinal Muscular Atrophy (SMA) Therapeutic Market
- Overview of the regional outlook of the Spinal Muscular Atrophy (SMA) Therapeutic Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Spinal Muscular Atrophy (SMA) Therapeutic Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Spinal Muscular Atrophy (SMA) Therapeutic
1.2 Key Market Segments
1.2.1 Spinal Muscular Atrophy (SMA) Therapeutic Segment by Type
1.2.2 Spinal Muscular Atrophy (SMA) Therapeutic Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 SPINAL MUSCULAR ATROPHY (SMA) THERAPEUTIC MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Spinal Muscular Atrophy (SMA) Therapeutic Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 SPINAL MUSCULAR ATROPHY (SMA) THERAPEUTIC MARKET COMPETITIVE LANDSCAPE
3.1 Global Spinal Muscular Atrophy (SMA) Therapeutic Sales by Manufacturers (2019-2024)
3.2 Global Spinal Muscular Atrophy (SMA) Therapeutic Revenue Market Share by Manufacturers (2019-2024)
3.3 Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Spinal Muscular Atrophy (SMA) Therapeutic Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Spinal Muscular Atrophy (SMA) Therapeutic Sales Sites, Area Served, Product Type
3.6 Spinal Muscular Atrophy (SMA) Therapeutic Market Competitive Situation and Trends
3.6.1 Spinal Muscular Atrophy (SMA) Therapeutic Market Concentration Rate
3.6.2 Global 5 and 10 Largest Spinal Muscular Atrophy (SMA) Therapeutic Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 SPINAL MUSCULAR ATROPHY (SMA) THERAPEUTIC INDUSTRY CHAIN ANALYSIS
4.1 Spinal Muscular Atrophy (SMA) Therapeutic Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF SPINAL MUSCULAR ATROPHY (SMA) THERAPEUTIC MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 SPINAL MUSCULAR ATROPHY (SMA) THERAPEUTIC MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Spinal Muscular Atrophy (SMA) Therapeutic Sales Market Share by Type (2019-2024)
6.3 Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Type (2019-2024)
6.4 Global Spinal Muscular Atrophy (SMA) Therapeutic Price by Type (2019-2024)
7 SPINAL MUSCULAR ATROPHY (SMA) THERAPEUTIC MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Spinal Muscular Atrophy (SMA) Therapeutic Market Sales by Application (2019-2024)
7.3 Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size (M USD) by Application (2019-2024)
7.4 Global Spinal Muscular Atrophy (SMA) Therapeutic Sales Growth Rate by Application (2019-2024)
8 SPINAL MUSCULAR ATROPHY (SMA) THERAPEUTIC MARKET SEGMENTATION BY REGION
8.1 Global Spinal Muscular Atrophy (SMA) Therapeutic Sales by Region
8.1.1 Global Spinal Muscular Atrophy (SMA) Therapeutic Sales by Region
8.1.2 Global Spinal Muscular Atrophy (SMA) Therapeutic Sales Market Share by Region
8.2 North America
8.2.1 North America Spinal Muscular Atrophy (SMA) Therapeutic Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Spinal Muscular Atrophy (SMA) Therapeutic Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Spinal Muscular Atrophy (SMA) Therapeutic Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Spinal Muscular Atrophy (SMA) Therapeutic Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Spinal Muscular Atrophy (SMA) Therapeutic Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Biogen
9.1.1 Biogen Spinal Muscular Atrophy (SMA) Therapeutic Basic Information
9.1.2 Biogen Spinal Muscular Atrophy (SMA) Therapeutic Product Overview
9.1.3 Biogen Spinal Muscular Atrophy (SMA) Therapeutic Product Market Performance
9.1.4 Biogen Business Overview
9.1.5 Biogen Spinal Muscular Atrophy (SMA) Therapeutic SWOT Analysis
9.1.6 Biogen Recent Developments
9.2 Novartis
9.2.1 Novartis Spinal Muscular Atrophy (SMA) Therapeutic Basic Information
9.2.2 Novartis Spinal Muscular Atrophy (SMA) Therapeutic Product Overview
9.2.3 Novartis Spinal Muscular Atrophy (SMA) Therapeutic Product Market Performance
9.2.4 Novartis Business Overview
9.2.5 Novartis Spinal Muscular Atrophy (SMA) Therapeutic SWOT Analysis
9.2.6 Novartis Recent Developments
9.3 Roche
9.3.1 Roche Spinal Muscular Atrophy (SMA) Therapeutic Basic Information
9.3.2 Roche Spinal Muscular Atrophy (SMA) Therapeutic Product Overview
9.3.3 Roche Spinal Muscular Atrophy (SMA) Therapeutic Product Market Performance
9.3.4 Roche Spinal Muscular Atrophy (SMA) Therapeutic SWOT Analysis
9.3.5 Roche Business Overview
9.3.6 Roche Recent Developments
9.4 Astellas Pharma
9.4.1 Astellas Pharma Spinal Muscular Atrophy (SMA) Therapeutic Basic Information
9.4.2 Astellas Pharma Spinal Muscular Atrophy (SMA) Therapeutic Product Overview
9.4.3 Astellas Pharma Spinal Muscular Atrophy (SMA) Therapeutic Product Market Performance
9.4.4 Astellas Pharma Business Overview
9.4.5 Astellas Pharma Recent Developments
9.5 Genzyme Corporation
9.5.1 Genzyme Corporation Spinal Muscular Atrophy (SMA) Therapeutic Basic Information
9.5.2 Genzyme Corporation Spinal Muscular Atrophy (SMA) Therapeutic Product Overview
9.5.3 Genzyme Corporation Spinal Muscular Atrophy (SMA) Therapeutic Product Market Performance
9.5.4 Genzyme Corporation Business Overview
9.5.5 Genzyme Corporation Recent Developments
10 SPINAL MUSCULAR ATROPHY (SMA) THERAPEUTIC MARKET FORECAST BY REGION
10.1 Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Forecast
10.2 Global Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size Forecast by Country
10.2.3 Asia Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Size Forecast by Region
10.2.4 South America Spinal Muscular Atrophy (SMA) Therapeutic Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Spinal Muscular Atrophy (SMA) Therapeutic by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Spinal Muscular Atrophy (SMA) Therapeutic by Type (2025-2030)
11.1.2 Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Spinal Muscular Atrophy (SMA) Therapeutic by Type (2025-2030)
11.2 Global Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast by Application (2025-2030)
11.2.1 Global Spinal Muscular Atrophy (SMA) Therapeutic Sales (K Units) Forecast by Application
11.2.2 Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Spinal Muscular Atrophy (SMA) Therapeutic
1.2 Key Market Segments
1.2.1 Spinal Muscular Atrophy (SMA) Therapeutic Segment by Type
1.2.2 Spinal Muscular Atrophy (SMA) Therapeutic Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 SPINAL MUSCULAR ATROPHY (SMA) THERAPEUTIC MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Spinal Muscular Atrophy (SMA) Therapeutic Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 SPINAL MUSCULAR ATROPHY (SMA) THERAPEUTIC MARKET COMPETITIVE LANDSCAPE
3.1 Global Spinal Muscular Atrophy (SMA) Therapeutic Sales by Manufacturers (2019-2024)
3.2 Global Spinal Muscular Atrophy (SMA) Therapeutic Revenue Market Share by Manufacturers (2019-2024)
3.3 Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Spinal Muscular Atrophy (SMA) Therapeutic Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Spinal Muscular Atrophy (SMA) Therapeutic Sales Sites, Area Served, Product Type
3.6 Spinal Muscular Atrophy (SMA) Therapeutic Market Competitive Situation and Trends
3.6.1 Spinal Muscular Atrophy (SMA) Therapeutic Market Concentration Rate
3.6.2 Global 5 and 10 Largest Spinal Muscular Atrophy (SMA) Therapeutic Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 SPINAL MUSCULAR ATROPHY (SMA) THERAPEUTIC INDUSTRY CHAIN ANALYSIS
4.1 Spinal Muscular Atrophy (SMA) Therapeutic Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF SPINAL MUSCULAR ATROPHY (SMA) THERAPEUTIC MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 SPINAL MUSCULAR ATROPHY (SMA) THERAPEUTIC MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Spinal Muscular Atrophy (SMA) Therapeutic Sales Market Share by Type (2019-2024)
6.3 Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Market Share by Type (2019-2024)
6.4 Global Spinal Muscular Atrophy (SMA) Therapeutic Price by Type (2019-2024)
7 SPINAL MUSCULAR ATROPHY (SMA) THERAPEUTIC MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Spinal Muscular Atrophy (SMA) Therapeutic Market Sales by Application (2019-2024)
7.3 Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size (M USD) by Application (2019-2024)
7.4 Global Spinal Muscular Atrophy (SMA) Therapeutic Sales Growth Rate by Application (2019-2024)
8 SPINAL MUSCULAR ATROPHY (SMA) THERAPEUTIC MARKET SEGMENTATION BY REGION
8.1 Global Spinal Muscular Atrophy (SMA) Therapeutic Sales by Region
8.1.1 Global Spinal Muscular Atrophy (SMA) Therapeutic Sales by Region
8.1.2 Global Spinal Muscular Atrophy (SMA) Therapeutic Sales Market Share by Region
8.2 North America
8.2.1 North America Spinal Muscular Atrophy (SMA) Therapeutic Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Spinal Muscular Atrophy (SMA) Therapeutic Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Spinal Muscular Atrophy (SMA) Therapeutic Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Spinal Muscular Atrophy (SMA) Therapeutic Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Spinal Muscular Atrophy (SMA) Therapeutic Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Biogen
9.1.1 Biogen Spinal Muscular Atrophy (SMA) Therapeutic Basic Information
9.1.2 Biogen Spinal Muscular Atrophy (SMA) Therapeutic Product Overview
9.1.3 Biogen Spinal Muscular Atrophy (SMA) Therapeutic Product Market Performance
9.1.4 Biogen Business Overview
9.1.5 Biogen Spinal Muscular Atrophy (SMA) Therapeutic SWOT Analysis
9.1.6 Biogen Recent Developments
9.2 Novartis
9.2.1 Novartis Spinal Muscular Atrophy (SMA) Therapeutic Basic Information
9.2.2 Novartis Spinal Muscular Atrophy (SMA) Therapeutic Product Overview
9.2.3 Novartis Spinal Muscular Atrophy (SMA) Therapeutic Product Market Performance
9.2.4 Novartis Business Overview
9.2.5 Novartis Spinal Muscular Atrophy (SMA) Therapeutic SWOT Analysis
9.2.6 Novartis Recent Developments
9.3 Roche
9.3.1 Roche Spinal Muscular Atrophy (SMA) Therapeutic Basic Information
9.3.2 Roche Spinal Muscular Atrophy (SMA) Therapeutic Product Overview
9.3.3 Roche Spinal Muscular Atrophy (SMA) Therapeutic Product Market Performance
9.3.4 Roche Spinal Muscular Atrophy (SMA) Therapeutic SWOT Analysis
9.3.5 Roche Business Overview
9.3.6 Roche Recent Developments
9.4 Astellas Pharma
9.4.1 Astellas Pharma Spinal Muscular Atrophy (SMA) Therapeutic Basic Information
9.4.2 Astellas Pharma Spinal Muscular Atrophy (SMA) Therapeutic Product Overview
9.4.3 Astellas Pharma Spinal Muscular Atrophy (SMA) Therapeutic Product Market Performance
9.4.4 Astellas Pharma Business Overview
9.4.5 Astellas Pharma Recent Developments
9.5 Genzyme Corporation
9.5.1 Genzyme Corporation Spinal Muscular Atrophy (SMA) Therapeutic Basic Information
9.5.2 Genzyme Corporation Spinal Muscular Atrophy (SMA) Therapeutic Product Overview
9.5.3 Genzyme Corporation Spinal Muscular Atrophy (SMA) Therapeutic Product Market Performance
9.5.4 Genzyme Corporation Business Overview
9.5.5 Genzyme Corporation Recent Developments
10 SPINAL MUSCULAR ATROPHY (SMA) THERAPEUTIC MARKET FORECAST BY REGION
10.1 Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Forecast
10.2 Global Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size Forecast by Country
10.2.3 Asia Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Size Forecast by Region
10.2.4 South America Spinal Muscular Atrophy (SMA) Therapeutic Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Spinal Muscular Atrophy (SMA) Therapeutic by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Spinal Muscular Atrophy (SMA) Therapeutic by Type (2025-2030)
11.1.2 Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Spinal Muscular Atrophy (SMA) Therapeutic by Type (2025-2030)
11.2 Global Spinal Muscular Atrophy (SMA) Therapeutic Market Forecast by Application (2025-2030)
11.2.1 Global Spinal Muscular Atrophy (SMA) Therapeutic Sales (K Units) Forecast by Application
11.2.2 Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Spinal Muscular Atrophy (SMA) Therapeutic Market Size Comparison by Region (M USD)
Table 5. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Spinal Muscular Atrophy (SMA) Therapeutic Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Spinal Muscular Atrophy (SMA) Therapeutic Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spinal Muscular Atrophy (SMA) Therapeutic as of 2022)
Table 10. Global Market Spinal Muscular Atrophy (SMA) Therapeutic Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Spinal Muscular Atrophy (SMA) Therapeutic Sales Sites and Area Served
Table 12. Manufacturers Spinal Muscular Atrophy (SMA) Therapeutic Product Type
Table 13. Global Spinal Muscular Atrophy (SMA) Therapeutic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Spinal Muscular Atrophy (SMA) Therapeutic
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Spinal Muscular Atrophy (SMA) Therapeutic Market Challenges
Table 22. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales by Type (K Units)
Table 23. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (M USD)
Table 24. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales (K Units) by Type (2019-2024)
Table 25. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales Market Share by Type (2019-2024)
Table 26. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size (M USD) by Type (2019-2024)
Table 27. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Share by Type (2019-2024)
Table 28. Global Spinal Muscular Atrophy (SMA) Therapeutic Price (USD/Unit) by Type (2019-2024)
Table 29. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales (K Units) by Application
Table 30. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application
Table 31. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales by Application (2019-2024) & (K Units)
Table 32. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales Market Share by Application (2019-2024)
Table 33. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales by Application (2019-2024) & (M USD)
Table 34. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Application (2019-2024)
Table 35. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales Growth Rate by Application (2019-2024)
Table 36. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales by Region (2019-2024) & (K Units)
Table 37. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales Market Share by Region (2019-2024)
Table 38. North America Spinal Muscular Atrophy (SMA) Therapeutic Sales by Country (2019-2024) & (K Units)
Table 39. Europe Spinal Muscular Atrophy (SMA) Therapeutic Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Spinal Muscular Atrophy (SMA) Therapeutic Sales by Region (2019-2024) & (K Units)
Table 41. South America Spinal Muscular Atrophy (SMA) Therapeutic Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Spinal Muscular Atrophy (SMA) Therapeutic Sales by Region (2019-2024) & (K Units)
Table 43. Biogen Spinal Muscular Atrophy (SMA) Therapeutic Basic Information
Table 44. Biogen Spinal Muscular Atrophy (SMA) Therapeutic Product Overview
Table 45. Biogen Spinal Muscular Atrophy (SMA) Therapeutic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Biogen Business Overview
Table 47. Biogen Spinal Muscular Atrophy (SMA) Therapeutic SWOT Analysis
Table 48. Biogen Recent Developments
Table 49. Novartis Spinal Muscular Atrophy (SMA) Therapeutic Basic Information
Table 50. Novartis Spinal Muscular Atrophy (SMA) Therapeutic Product Overview
Table 51. Novartis Spinal Muscular Atrophy (SMA) Therapeutic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Novartis Business Overview
Table 53. Novartis Spinal Muscular Atrophy (SMA) Therapeutic SWOT Analysis
Table 54. Novartis Recent Developments
Table 55. Roche Spinal Muscular Atrophy (SMA) Therapeutic Basic Information
Table 56. Roche Spinal Muscular Atrophy (SMA) Therapeutic Product Overview
Table 57. Roche Spinal Muscular Atrophy (SMA) Therapeutic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Roche Spinal Muscular Atrophy (SMA) Therapeutic SWOT Analysis
Table 59. Roche Business Overview
Table 60. Roche Recent Developments
Table 61. Astellas Pharma Spinal Muscular Atrophy (SMA) Therapeutic Basic Information
Table 62. Astellas Pharma Spinal Muscular Atrophy (SMA) Therapeutic Product Overview
Table 63. Astellas Pharma Spinal Muscular Atrophy (SMA) Therapeutic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Astellas Pharma Business Overview
Table 65. Astellas Pharma Recent Developments
Table 66. Genzyme Corporation Spinal Muscular Atrophy (SMA) Therapeutic Basic Information
Table 67. Genzyme Corporation Spinal Muscular Atrophy (SMA) Therapeutic Product Overview
Table 68. Genzyme Corporation Spinal Muscular Atrophy (SMA) Therapeutic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Genzyme Corporation Business Overview
Table 70. Genzyme Corporation Recent Developments
Table 71. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales Forecast by Region (2025-2030) & (K Units)
Table 72. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Forecast by Region (2025-2030) & (M USD)
Table 73. North America Spinal Muscular Atrophy (SMA) Therapeutic Sales Forecast by Country (2025-2030) & (K Units)
Table 74. North America Spinal Muscular Atrophy (SMA) Therapeutic Market Size Forecast by Country (2025-2030) & (M USD)
Table 75. Europe Spinal Muscular Atrophy (SMA) Therapeutic Sales Forecast by Country (2025-2030) & (K Units)
Table 76. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size Forecast by Country (2025-2030) & (M USD)
Table 77. Asia Pacific Spinal Muscular Atrophy (SMA) Therapeutic Sales Forecast by Region (2025-2030) & (K Units)
Table 78. Asia Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Size Forecast by Region (2025-2030) & (M USD)
Table 79. South America Spinal Muscular Atrophy (SMA) Therapeutic Sales Forecast by Country (2025-2030) & (K Units)
Table 80. South America Spinal Muscular Atrophy (SMA) Therapeutic Market Size Forecast by Country (2025-2030) & (M USD)
Table 81. Middle East and Africa Spinal Muscular Atrophy (SMA) Therapeutic Consumption Forecast by Country (2025-2030) & (Units)
Table 82. Middle East and Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size Forecast by Country (2025-2030) & (M USD)
Table 83. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales Forecast by Type (2025-2030) & (K Units)
Table 84. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Forecast by Type (2025-2030) & (M USD)
Table 85. Global Spinal Muscular Atrophy (SMA) Therapeutic Price Forecast by Type (2025-2030) & (USD/Unit)
Table 86. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales (K Units) Forecast by Application (2025-2030)
Table 87. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Spinal Muscular Atrophy (SMA) Therapeutic Market Size Comparison by Region (M USD)
Table 5. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Spinal Muscular Atrophy (SMA) Therapeutic Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Spinal Muscular Atrophy (SMA) Therapeutic Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spinal Muscular Atrophy (SMA) Therapeutic as of 2022)
Table 10. Global Market Spinal Muscular Atrophy (SMA) Therapeutic Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Spinal Muscular Atrophy (SMA) Therapeutic Sales Sites and Area Served
Table 12. Manufacturers Spinal Muscular Atrophy (SMA) Therapeutic Product Type
Table 13. Global Spinal Muscular Atrophy (SMA) Therapeutic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Spinal Muscular Atrophy (SMA) Therapeutic
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Spinal Muscular Atrophy (SMA) Therapeutic Market Challenges
Table 22. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales by Type (K Units)
Table 23. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (M USD)
Table 24. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales (K Units) by Type (2019-2024)
Table 25. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales Market Share by Type (2019-2024)
Table 26. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size (M USD) by Type (2019-2024)
Table 27. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Share by Type (2019-2024)
Table 28. Global Spinal Muscular Atrophy (SMA) Therapeutic Price (USD/Unit) by Type (2019-2024)
Table 29. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales (K Units) by Application
Table 30. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application
Table 31. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales by Application (2019-2024) & (K Units)
Table 32. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales Market Share by Application (2019-2024)
Table 33. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales by Application (2019-2024) & (M USD)
Table 34. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Application (2019-2024)
Table 35. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales Growth Rate by Application (2019-2024)
Table 36. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales by Region (2019-2024) & (K Units)
Table 37. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales Market Share by Region (2019-2024)
Table 38. North America Spinal Muscular Atrophy (SMA) Therapeutic Sales by Country (2019-2024) & (K Units)
Table 39. Europe Spinal Muscular Atrophy (SMA) Therapeutic Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Spinal Muscular Atrophy (SMA) Therapeutic Sales by Region (2019-2024) & (K Units)
Table 41. South America Spinal Muscular Atrophy (SMA) Therapeutic Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Spinal Muscular Atrophy (SMA) Therapeutic Sales by Region (2019-2024) & (K Units)
Table 43. Biogen Spinal Muscular Atrophy (SMA) Therapeutic Basic Information
Table 44. Biogen Spinal Muscular Atrophy (SMA) Therapeutic Product Overview
Table 45. Biogen Spinal Muscular Atrophy (SMA) Therapeutic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Biogen Business Overview
Table 47. Biogen Spinal Muscular Atrophy (SMA) Therapeutic SWOT Analysis
Table 48. Biogen Recent Developments
Table 49. Novartis Spinal Muscular Atrophy (SMA) Therapeutic Basic Information
Table 50. Novartis Spinal Muscular Atrophy (SMA) Therapeutic Product Overview
Table 51. Novartis Spinal Muscular Atrophy (SMA) Therapeutic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Novartis Business Overview
Table 53. Novartis Spinal Muscular Atrophy (SMA) Therapeutic SWOT Analysis
Table 54. Novartis Recent Developments
Table 55. Roche Spinal Muscular Atrophy (SMA) Therapeutic Basic Information
Table 56. Roche Spinal Muscular Atrophy (SMA) Therapeutic Product Overview
Table 57. Roche Spinal Muscular Atrophy (SMA) Therapeutic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Roche Spinal Muscular Atrophy (SMA) Therapeutic SWOT Analysis
Table 59. Roche Business Overview
Table 60. Roche Recent Developments
Table 61. Astellas Pharma Spinal Muscular Atrophy (SMA) Therapeutic Basic Information
Table 62. Astellas Pharma Spinal Muscular Atrophy (SMA) Therapeutic Product Overview
Table 63. Astellas Pharma Spinal Muscular Atrophy (SMA) Therapeutic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Astellas Pharma Business Overview
Table 65. Astellas Pharma Recent Developments
Table 66. Genzyme Corporation Spinal Muscular Atrophy (SMA) Therapeutic Basic Information
Table 67. Genzyme Corporation Spinal Muscular Atrophy (SMA) Therapeutic Product Overview
Table 68. Genzyme Corporation Spinal Muscular Atrophy (SMA) Therapeutic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Genzyme Corporation Business Overview
Table 70. Genzyme Corporation Recent Developments
Table 71. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales Forecast by Region (2025-2030) & (K Units)
Table 72. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Forecast by Region (2025-2030) & (M USD)
Table 73. North America Spinal Muscular Atrophy (SMA) Therapeutic Sales Forecast by Country (2025-2030) & (K Units)
Table 74. North America Spinal Muscular Atrophy (SMA) Therapeutic Market Size Forecast by Country (2025-2030) & (M USD)
Table 75. Europe Spinal Muscular Atrophy (SMA) Therapeutic Sales Forecast by Country (2025-2030) & (K Units)
Table 76. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size Forecast by Country (2025-2030) & (M USD)
Table 77. Asia Pacific Spinal Muscular Atrophy (SMA) Therapeutic Sales Forecast by Region (2025-2030) & (K Units)
Table 78. Asia Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Size Forecast by Region (2025-2030) & (M USD)
Table 79. South America Spinal Muscular Atrophy (SMA) Therapeutic Sales Forecast by Country (2025-2030) & (K Units)
Table 80. South America Spinal Muscular Atrophy (SMA) Therapeutic Market Size Forecast by Country (2025-2030) & (M USD)
Table 81. Middle East and Africa Spinal Muscular Atrophy (SMA) Therapeutic Consumption Forecast by Country (2025-2030) & (Units)
Table 82. Middle East and Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size Forecast by Country (2025-2030) & (M USD)
Table 83. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales Forecast by Type (2025-2030) & (K Units)
Table 84. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Forecast by Type (2025-2030) & (M USD)
Table 85. Global Spinal Muscular Atrophy (SMA) Therapeutic Price Forecast by Type (2025-2030) & (USD/Unit)
Table 86. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales (K Units) Forecast by Application (2025-2030)
Table 87. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Spinal Muscular Atrophy (SMA) Therapeutic
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size (M USD), 2019-2030
Figure 5. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size (M USD) (2019-2030)
Figure 6. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country (M USD)
Figure 11. Spinal Muscular Atrophy (SMA) Therapeutic Sales Share by Manufacturers in 2023
Figure 12. Global Spinal Muscular Atrophy (SMA) Therapeutic Revenue Share by Manufacturers in 2023
Figure 13. Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Spinal Muscular Atrophy (SMA) Therapeutic Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Spinal Muscular Atrophy (SMA) Therapeutic Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Type
Figure 18. Sales Market Share of Spinal Muscular Atrophy (SMA) Therapeutic by Type (2019-2024)
Figure 19. Sales Market Share of Spinal Muscular Atrophy (SMA) Therapeutic by Type in 2023
Figure 20. Market Size Share of Spinal Muscular Atrophy (SMA) Therapeutic by Type (2019-2024)
Figure 21. Market Size Market Share of Spinal Muscular Atrophy (SMA) Therapeutic by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Application
Figure 24. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales Market Share by Application (2019-2024)
Figure 25. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales Market Share by Application in 2023
Figure 26. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Application (2019-2024)
Figure 27. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Application in 2023
Figure 28. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales Growth Rate by Application (2019-2024)
Figure 29. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales Market Share by Region (2019-2024)
Figure 30. North America Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Spinal Muscular Atrophy (SMA) Therapeutic Sales Market Share by Country in 2023
Figure 32. U.S. Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Spinal Muscular Atrophy (SMA) Therapeutic Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Spinal Muscular Atrophy (SMA) Therapeutic Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Spinal Muscular Atrophy (SMA) Therapeutic Sales Market Share by Country in 2023
Figure 37. Germany Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Spinal Muscular Atrophy (SMA) Therapeutic Sales Market Share by Region in 2023
Figure 44. China Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (K Units)
Figure 50. South America Spinal Muscular Atrophy (SMA) Therapeutic Sales Market Share by Country in 2023
Figure 51. Brazil Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Spinal Muscular Atrophy (SMA) Therapeutic Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Share Forecast by Type (2025-2030)
Figure 65. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales Forecast by Application (2025-2030)
Figure 66. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Spinal Muscular Atrophy (SMA) Therapeutic
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size (M USD), 2019-2030
Figure 5. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size (M USD) (2019-2030)
Figure 6. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country (M USD)
Figure 11. Spinal Muscular Atrophy (SMA) Therapeutic Sales Share by Manufacturers in 2023
Figure 12. Global Spinal Muscular Atrophy (SMA) Therapeutic Revenue Share by Manufacturers in 2023
Figure 13. Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Spinal Muscular Atrophy (SMA) Therapeutic Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Spinal Muscular Atrophy (SMA) Therapeutic Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Type
Figure 18. Sales Market Share of Spinal Muscular Atrophy (SMA) Therapeutic by Type (2019-2024)
Figure 19. Sales Market Share of Spinal Muscular Atrophy (SMA) Therapeutic by Type in 2023
Figure 20. Market Size Share of Spinal Muscular Atrophy (SMA) Therapeutic by Type (2019-2024)
Figure 21. Market Size Market Share of Spinal Muscular Atrophy (SMA) Therapeutic by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Application
Figure 24. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales Market Share by Application (2019-2024)
Figure 25. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales Market Share by Application in 2023
Figure 26. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Application (2019-2024)
Figure 27. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Application in 2023
Figure 28. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales Growth Rate by Application (2019-2024)
Figure 29. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales Market Share by Region (2019-2024)
Figure 30. North America Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Spinal Muscular Atrophy (SMA) Therapeutic Sales Market Share by Country in 2023
Figure 32. U.S. Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Spinal Muscular Atrophy (SMA) Therapeutic Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Spinal Muscular Atrophy (SMA) Therapeutic Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Spinal Muscular Atrophy (SMA) Therapeutic Sales Market Share by Country in 2023
Figure 37. Germany Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Spinal Muscular Atrophy (SMA) Therapeutic Sales Market Share by Region in 2023
Figure 44. China Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (K Units)
Figure 50. South America Spinal Muscular Atrophy (SMA) Therapeutic Sales Market Share by Country in 2023
Figure 51. Brazil Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Spinal Muscular Atrophy (SMA) Therapeutic Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Spinal Muscular Atrophy (SMA) Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Share Forecast by Type (2025-2030)
Figure 65. Global Spinal Muscular Atrophy (SMA) Therapeutic Sales Forecast by Application (2025-2030)
Figure 66. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Share Forecast by Application (2025-2030)
